These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 22437117)

  • 1. Lead optimisation of the N1 substituent of a novel series of indazole arylsulfonamides as CCR4 antagonists and identification of a candidate for clinical investigation.
    Procopiou PA; Ford AJ; Graves RH; Hall DA; Hodgson ST; Lacroix YM; Needham D; Slack RJ
    Bioorg Med Chem Lett; 2012 Apr; 22(8):2730-3. PubMed ID: 22437117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and structure-activity relationships of indazole arylsulfonamides as allosteric CC-chemokine receptor 4 (CCR4) antagonists.
    Procopiou PA; Barrett JW; Barton NP; Begg M; Clapham D; Copley RC; Ford AJ; Graves RH; Hall DA; Hancock AP; Hill AP; Hobbs H; Hodgson ST; Jumeaux C; Lacroix YM; Miah AH; Morriss KM; Needham D; Sheriff EB; Slack RJ; Smith CE; Sollis SL; Staton H
    J Med Chem; 2013 Mar; 56(5):1946-60. PubMed ID: 23409871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lead identification of benzimidazolone and azabenzimidazolone arylsulfonamides as CC-chemokine receptor 4 (CCR4) antagonists.
    Miah AH; Abas H; Begg M; Marsh BJ; O'Flynn DE; Ford AJ; Percy JM; Procopiou PA; Richards SA; Rumley SA
    Bioorg Med Chem; 2014 Aug; 22(15):4298-311. PubMed ID: 24909677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of pyrazolopyrimidine arylsulfonamides as CC-chemokine receptor 4 (CCR4) antagonists.
    Miah AH; Champigny AC; Graves RH; Hodgson ST; Percy JM; Procopiou PA
    Bioorg Med Chem; 2017 Oct; 25(20):5327-5340. PubMed ID: 28801066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and optimisation of novel sulfonamide, selective vasopressin V1B receptor antagonists.
    Baker J; Bingham M; Blackburn-Munro R; Cai J; Craighead M; Gilfillan R; Goan K; Jaap D; Milne R; Morphy JR; Napier S; Presland J; Spinks G; Thomson F
    Bioorg Med Chem Lett; 2011 Jun; 21(12):3603-7. PubMed ID: 21601454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small molecule antagonists of the CC chemokine receptor 4 (CCR4).
    Burdi DF; Chi S; Mattia K; Harrington C; Shi Z; Chen S; Jacutin-Porte S; Bennett R; Carson K; Yin W; Kansra V; Gonzalo JA; Coyle A; Jaffee B; Ocain T; Hodge M; LaRosa G; Harriman G
    Bioorg Med Chem Lett; 2007 Jun; 17(11):3141-5. PubMed ID: 17395464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and structure-activity relationships of novel indazolyl glucocorticoid receptor partial agonists.
    Gilmore JL; Sheppeck JE; Wang J; Dhar TG; Cavallaro C; Doweyko AM; Mckay L; Cunningham MD; Habte SF; Nadler SG; Dodd JH; Somerville JE; Barrish JC
    Bioorg Med Chem Lett; 2013 Oct; 23(19):5448-51. PubMed ID: 23916594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of a potent series of non-steroidal non α-trifluoromethyl carbinol glucocorticoid receptor agonists with reduced lipophilicity.
    Diallo H; Angell DC; Barnett HA; Biggadike K; Coe DM; Cooper TW; Craven A; Gray JR; House D; Jack TI; Keeling SP; Macdonald SJ; McLay IM; Oliver S; Taylor SJ; Uings IJ; Wellaway N
    Bioorg Med Chem Lett; 2011 Feb; 21(4):1126-33. PubMed ID: 21257309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-based design, synthesis, and antimicrobial activity of indazole-derived SAH/MTA nucleosidase inhibitors.
    Li X; Chu S; Feher VA; Khalili M; Nie Z; Margosiak S; Nikulin V; Levin J; Sprankle KG; Tedder ME; Almassy R; Appelt K; Yager KM
    J Med Chem; 2003 Dec; 46(26):5663-73. PubMed ID: 14667220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of N-(7-indazolyl)benzenesulfonamide derivatives as potent cell cycle inhibitors.
    Bouissane L; El Kazzouli S; Léonce S; Pfeiffer B; Rakib EM; Khouili M; Guillaumet G
    Bioorg Med Chem; 2006 Feb; 14(4):1078-88. PubMed ID: 16274996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcitonin gene-related peptide (CGRP) receptor antagonists: novel aspartates and succinates.
    Luo G; Chen L; Pin SS; Xu C; Conway CM; Macor JE; Dubowchik GM
    Bioorg Med Chem Lett; 2012 Apr; 22(8):2912-6. PubMed ID: 22429471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lead identification and structure-activity relationships of heteroarylpyrazole arylsulfonamides as allosteric CC-chemokine receptor 4 (CCR4) antagonists.
    Miah AH; Copley RC; O'Flynn D; Percy JM; Procopiou PA
    Org Biomol Chem; 2014 Mar; 12(11):1779-92. PubMed ID: 24515101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and structure-activity relationship of 3-benzimidazol-2-yl-1H-indazoles as inhibitors of receptor tyrosine kinases.
    McBride CM; Renhowe PA; Heise C; Jansen JM; Lapointe G; Ma S; Piñeda R; Vora J; Wiesmann M; Shafer CM
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3595-9. PubMed ID: 16603352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bipiperidinyl carboxylic acid amides as potent, selective, and functionally active CCR4 antagonists.
    Kuhn CF; Bazin M; Philippe L; Zhang J; Tylaska L; Miret J; Bauer PH
    Chem Biol Drug Des; 2007 Sep; 70(3):268-72. PubMed ID: 17718722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and evaluation of naphthalene-sulfonamide antagonists of human CCR8.
    Jenkins TJ; Guan B; Dai M; Li G; Lightburn TE; Huang S; Freeze BS; Burdi DF; Jacutin-Porte S; Bennett R; Chen W; Minor C; Ghosh S; Blackburn C; Gigstad KM; Jones M; Kolbeck R; Yin W; Smith S; Cardillo D; Ocain TD; Harriman GC
    J Med Chem; 2007 Feb; 50(3):566-84. PubMed ID: 17266208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of indazoles as inhibitors of Tpl2 kinase.
    Hu Y; Cole D; Denny RA; Anderson DR; Ipek M; Ni Y; Wang X; Thaisrivongs S; Chamberlain T; Hall JP; Liu J; Luong M; Lin LL; Telliez JB; Gopalsamy A
    Bioorg Med Chem Lett; 2011 Aug; 21(16):4758-61. PubMed ID: 21742493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of novel azaindazole CCR1 antagonist clinical candidates.
    Harcken C; Kuzmich D; Cook B; Mao C; Disalvo D; Razavi H; Swinamer A; Liu P; Zhang Q; Kukulka A; Skow D; Patel M; Patel M; Fletcher K; Sherry T; Joseph D; Smith D; Canfield M; Souza D; Bogdanffy M; Berg K; Brown M
    Bioorg Med Chem Lett; 2019 Feb; 29(3):441-448. PubMed ID: 30595446
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and SAR of trisubstituted thiazolidinones as CCR4 antagonists.
    Allen S; Newhouse B; Anderson AS; Fauber B; Allen A; Chantry D; Eberhardt C; Odingo J; Burgess LE
    Bioorg Med Chem Lett; 2004 Apr; 14(7):1619-24. PubMed ID: 15026036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of chemokine receptor CCR4 antagonist.
    Purandare AV; Gao A; Wan H; Somerville J; Burke C; Seachord C; Vaccaro W; Wityak J; Poss MA
    Bioorg Med Chem Lett; 2005 May; 15(10):2669-72. PubMed ID: 15863339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Core exploration in optimization of chemokine receptor CCR4 antagonists.
    Purandare AV; Wan H; Somerville JE; Burke C; Vaccaro W; Yang X; McIntyre KW; Poss MA
    Bioorg Med Chem Lett; 2007 Feb; 17(3):679-82. PubMed ID: 17098428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.